Want to see IMCR full AI Analyst Report?
Immunocore Holdings (IMCR) Income Statement
Immunocore Holdings Income Statement
Last quarter (Q2 2026), Immunocore Holdings's total revenue was $115.93M, an increase of 18.34% from the same quarter last year. In Q2, Immunocore Holdings's net income was $-808.00K. See Immunocore Holdings’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 297.57M | $ 247.98M | $ 197.39M | $ 144.23M | $ 27.04M | |
| $ 291.36M | $ 242.44M | $ 196.57M | $ 138.94M | $ 27.04M | |
| $ 325.09M | $ 298.77M | $ 243.77M | $ 181.71M | $ 156.46M | |
| Depreciation and Amortization | $ 2.43M | $ 4.20M | $ 3.24M | ― | ― |
| $ 387.18K | $ -37.66M | $ -40.87M | ― | ― | |
| $ -33.74M | $ -56.28M | $ -47.20M | $ -42.77M | $ -129.42M | |
| $ 19.53M | $ 14.01M | $ -982.07K | $ 8.95M | $ -3.92M | |
| $ -14.21M | $ -42.32M | $ -48.19M | $ -33.82M | $ -133.34M | |
| $ -26.42M | $ -40.81M | $ -43.75M | $ -43.46M | $ -133.45M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.53 | $ -1.02 | $ -0.89 | $ -0.95 | $ -3.13 |
| Diluted EPS | $ -0.53 | $ -1.02 | $ -0.89 | $ -0.95 | $ -3.00 |
| Weighted Average Shares Outstanding | 50.35M | 49.99M | 48.89M | 45.71M | 42.49M |
| Weighted Average Shares Outstanding (Diluted) | 50.35M | 49.99M | 48.89M | 45.71M | 43.86M |
Currency in GBP
